Xiaosuo Wang | Technological Networks | Best Researcher Award

Published on by Network Science

Dr. Xiaosuo Wang | Technological Networks | Best Researcher Award

The University of Sydney | Australia

Dr. Xiaosuo Wang is a distinguished researcher specializing in mass spectrometry, metabolomics, lipidomics, and proteomics, with deep expertise in vascular biology and heart failure. She earned her PhD in Medicine from the University of Sydney in 2009, focusing on novel ELISA methods to detect oxidised apolipoproteins in cardiovascular disease, following a master’s degree in Physiology and Pharmacology from the University of New South Wales and a bachelor’s in Biomedical Engineering from the Fourth Military Medical University, China. Currently a Senior Research Fellow and Senior Lecturer at the University of Sydney’s Charles Perkins Centre, she leads pioneering projects in biomarker discovery, metabolic assays, and multi-omics platform development for applications in liver disease, heart failure, and population health. Her work integrates advanced mass spectrometry, lipidomics, and metabolomics workflows with translational innovations such as point-of-care assays and biosensor development. Previously, as a Metabolomics Research Scientist at the Victor Chang Cardiac Research Institute and Manager of the Bosch Mass Spectrometry Facility, she developed over 60 advanced LC-MS assays and supported a wide range of biological and clinical research. Dr. Wang’s prolific contributions include more than 40 peer-reviewed publications, numerous conference presentations, and significant advancements in analytical methodologies for precision medicine.

Profiles: Scopus | Orcid ID

Featured Publications

"Rapid On-Demand Point-of-Care Monitoring of Clozapine and Its Metabolite Norclozapine Using Miniature Mass Spectrometry. Pharmaceuticals, Xiaosuo Wang; Wei Yi Lew; Yang Yang; Nan Zhang; Jiexun Bu; Zhentao Li; Michael Fitzpatrick; Paul Bonnitcha; David Sullivan; Wenpeng Zhang et al., 2025"

"The Heart Has Intrinsic Ketogenic Capacity that Mediates NAD + Therapy in HFpEF, Circulation Research, Yen Chin Koay; Bailey McIntosh; Yann Huey Ng; Yang Cao; Xiao Suo Wang; Yanchuang Han; Saki Tomita; Angela Yu Bai; Benjamin Hunter; Ashish Misra et al., 2025"

"Cardiac Substrate Utilization and Relationship to Invasive Exercise Hemodynamic Parameters in HFpEF, JACC. Basic to translational science, O'Sullivan JF; Li M; Koay YC; Wang XS; Guglielmi G; Marques FZ; Nanayakkara S; Mariani J; Slaughter E; Kaye DM, 2024"

"The first human normative ranges and biomarker performance of dimethylguanidino valeric acid isoforms in fatty liver disease, Pathology, Qadri S; Wang X; Tran C; Fitzpatrick M; Bonnitcha P; Sullivan D; Yki-Järvinen H; O'Sullivan JF, 2023"

"Destabilization of Atherosclerotic Plaque by Bilirubin Deficiency, Circulation Research, Weiyu Chen; Sergey Tumanov; Christopher P. Stanley; Stephanie M.Y. Kong; James Nadel; Niv Vigder; Darren L. Newington; Xiao Suo Wang; Louise L. Dunn; Roland Stocker, 2025"

Laina Ageliki | Cardiology | Best Researcher Award

Published on by Network Science

Dr. Laina Ageliki | Cardiology | Best Researcher Award

National and Kapodistrian University of Athen | Greece

Dr. Laina Ageliki completed her medical studies at the Aristotle University of Thessaloniki in 2012 and holds a Medical Association License in Athens (Protocol No. 188289/2586). She earned an MSc in Cardiopulmonary Resuscitation from the National and Kapodistrian University of Athens (2013–2015, grade A) and is currently pursuing a PhD in Medicine on “The role of proteasome inhibition in vascular function and atherosclerosis in humans” at the University of Athens. Her clinical experience includes serving as a rural service doctor in Tzoumerka, completing residencies in Internal Medicine at “Amalia Fleming” General Hospital (2013–2016) and in Cardiology at the 1st Cardiology Department, Hippokration Hospital, Athens (2018–2023), followed by a scientific associate position in the Electrophysiology Laboratory (2023–2025) and currently a cardiac electrophysiology and pacing fellowship at Clinique Pasteur, Toulouse, France. Dr. Ageliki has actively contributed to multiple clinical trials, including RELAX-HF, PAVE-AF, ReCONSIDER, READAPT, Librexia AF, Protect ICD, and the Enlighten EV-ICD registry. She has received recognition for her research, including the Best Oral Announcement at the 29th Congress of the Hellenic Society of Haematology (2018) and a scholarship from the Hellenic Foundation for Research & Innovation (ELIDEK, 2016). Additionally, she has authored book chapters on cardiovascular topics and contributes to the Greek medical journal HEART and VESSELS.

Profiles: Orcid ID | Scopus

Featured Publications

"CRT-D or CRT-P: When There Is a Dilemma and How to Solve it"

"Clinical, Electrocardiographic and Echocardiographic Predictors of Atrial Fibrillation Recurrence After Pulmonary Vein Isolation"

"Aggressive Rhythm Control Strategy in Atrial Fibrillation Patients Presenting at the Emergency Department: The HEROMEDICUS Study Design and Initial Results"

"Cardiac mechanics in response to proteasome inhibition: a prospective study"

"Cardiovascular Toxicity of Proteasome Inhibitors: Underlying Mechanisms and Management Strategies: JACC: CardioOncology State-of-the-Art Review"